JoEllyn McMillan

About JoEllyn McMillan

JoEllyn McMillan, With an exceptional h-index of 43 and a recent h-index of 30 (since 2020), a distinguished researcher at University of Nebraska Medical Center, specializes in the field of Nanomedicine, Neuroimmune toxicology, Reactive metabolite toxicology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

Pathways for dolutegravir transformation from a daily oral to a once-a-year parenteral medicine

A link between methylglyoxal and heart failure during HIV-1 infection

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

CRISPR-Cas9 mediated exonic disruption for HIV-1 elimination

Dolutegravir inhibition of matrix metalloproteinases affects mouse neurodevelopment

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles

Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue

JoEllyn McMillan Information

University

Position

___

Citations(all)

5571

Citations(since 2020)

3165

Cited By

3569

hIndex(all)

43

hIndex(since 2020)

30

i10Index(all)

96

i10Index(since 2020)

67

Email

University Profile Page

Google Scholar

JoEllyn McMillan Skills & Research Interests

Nanomedicine

Neuroimmune toxicology

Reactive metabolite toxicology

Top articles of JoEllyn McMillan

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

Nature communications

2022/6/9

Pathways for dolutegravir transformation from a daily oral to a once-a-year parenteral medicine

2022/1/21

A link between methylglyoxal and heart failure during HIV-1 infection

Frontiers in cardiovascular medicine

2021/12/14

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

Molecular neurodegeneration

2021/12

CRISPR-Cas9 mediated exonic disruption for HIV-1 elimination

EBioMedicine

2021/11/1

Dolutegravir inhibition of matrix metalloproteinases affects mouse neurodevelopment

Molecular Neurobiology

2021/11

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles

Nature Communications

2021/9/16

Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue

Aids

2021/9/1

Joellyn Mcmillan
Joellyn Mcmillan

H-Index: 29

Yutong Liu
Yutong Liu

H-Index: 3

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir

Nature communications

2021/6/8

Efavirenz, atazanavir, and ritonavir disrupt sarcoplasmic reticulum Ca2+ homeostasis in skeletal muscles

Antiviral research

2021/3/1

Exonic Disruption Facilitates Antiviral CRISPR-Cas9 Activity for Multistrain HIV-1 Elimination

bioRxiv

2021/1/14

Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs

Nanotheranostics

2021

A year-long extended release nanoformulated cabotegravir prodrug

Nature materials

2020/8

Adeno-associated viral transfer of glyoxalase-1 blunts carbonyl and oxidative stresses in hearts of type 1 diabetic rats

Antioxidants

2020/7/6

Joellyn Mcmillan
Joellyn Mcmillan

H-Index: 29

Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking

Biomaterials

2020/2/1

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues

Theranostics

2020

Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research

2020/9/1

See List of Professors in JoEllyn McMillan University(University of Nebraska Medical Center)

Co-Authors

academic-engine